PROMISE international; a clinical post marketing trial investigating the percutaneous deep vein arterialization (LimFlow) in the treatment of no-option chronic limb ischemia patient

BACKGROUND: Critical limb ischemia (CLI) is the clinical end stage of peripheral artery disease and is associated with high amputation, mortality rates and poor quality of life. For CLI patients with no revascularization options, venous arterialization could be an alternative technique for limb salv...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreve, Michiel A., Lichtenberg, Michael, Ünlü, Çagdas, Branzan, Daniela, Schmidt, Andrej, van den Heuvel, Daniel A. F., Blessing, Erwin, Brodmann, Marianne, Cabane, Vincent, Lin, William Tan Qing, Kum, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966404/
https://www.ncbi.nlm.nih.gov/pubmed/32026120
http://dx.doi.org/10.1186/s42155-019-0067-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966404/
https://www.ncbi.nlm.nih.gov/pubmed/32026120
http://dx.doi.org/10.1186/s42155-019-0067-z

Ejemplares similares